Shandong Weigao Group Medical Polymer Company Limited
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company's medical device pro… Read more
Shandong Weigao Group Medical Polymer Company Limited - Asset Resilience Ratio
Shandong Weigao Group Medical Polymer Company Limited (UK2) has an Asset Resilience Ratio of 1.96% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2024)
This chart shows how Shandong Weigao Group Medical Polymer Company Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Shandong Weigao Group Medical Polymer Company Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €707.20 Million | 1.96% |
| Total Liquid Assets | €707.20 Million | 1.96% |
Asset Resilience Insights
- Limited Liquidity: Shandong Weigao Group Medical Polymer Company Limited maintains only 1.96% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shandong Weigao Group Medical Polymer Company Limited Industry Peers by Asset Resilience Ratio
Compare Shandong Weigao Group Medical Polymer Company Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931 |
Medical Instruments & Supplies | 0.06% |
|
Blue Sail Medical Co Ltd
SHE:002382 |
Medical Instruments & Supplies | 5.12% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 35.75% |
|
Allmed Medical Products Co Ltd Class A
SHE:002950 |
Medical Instruments & Supplies | 3.78% |
|
Inix Technologies Holdings Bhd
KLSE:0094 |
Medical Instruments & Supplies | 0.06% |
|
Focus Point Holdings Bhd
KLSE:0157 |
Medical Instruments & Supplies | 2.30% |
|
Careplus Group Bhd
KLSE:0163 |
Medical Instruments & Supplies | 4.91% |
|
LKL International Bhd
KLSE:0182 |
Medical Instruments & Supplies | 0.38% |
Annual Asset Resilience Ratio for Shandong Weigao Group Medical Polymer Company Limited (2013–2024)
The table below shows the annual Asset Resilience Ratio data for Shandong Weigao Group Medical Polymer Company Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.56% | €541.50 Million | €34.76 Billion | +0.53pp |
| 2023-12-31 | 1.02% | €344.58 Million | €33.67 Billion | -0.47pp |
| 2022-12-31 | 1.49% | €495.34 Million | €33.20 Billion | +0.08pp |
| 2021-12-31 | 1.42% | €429.75 Million | €30.37 Billion | -0.30pp |
| 2020-12-31 | 1.72% | €469.61 Million | €27.34 Billion | +0.11pp |
| 2019-12-31 | 1.60% | €421.88 Million | €26.33 Billion | +0.15pp |
| 2018-12-31 | 1.46% | €349.53 Million | €23.99 Billion | +1.10pp |
| 2013-12-31 | 0.35% | €40.00 Million | €11.29 Billion | -- |